Fig. 2
From: Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer
Expression of MIR502 affected the overall survival of OC patients. Kaplan-Meier analysis of overall survival (OS) in OC patients based on the K-M plotter dataset. a-eMIR21, MIR29c, MIR99a, MIR101 and MIR4324 expression is not correlated with OS in OC patients. fMIR532 is positively correlated with OS in OC patients, P < 0.05. gMIR502 is positively correlated with OS in OC patients, P < 0.01. h The expression level of MIR502 in normal and ovarian cancer tissues from GSE83693 (normal tissues, n = 4; OC tissues, n = 8, P < 0.01). I The expression level of MIR502 in normal and ovarian cancer tissues from GSE119055 (normal tissues, n = 3; OC tissues, n = 6, P < 0.05). **P < 0.01, *P < 0.05